Susan G. Komen’s Post

Happening now! People diagnosed with early ER-positive breast cancer are likely to be cured of their breast cancer, but some will still experience a recurrence. In this episode of Breast Cancer Breakthroughs, hear from experts Dr. Sara Tolaney and Dr. Aditya Bardia about how researchers are working to find ways to lower risk for recurrence and how new research on early ER-positive breast cancer can save lives. Watch here: https://bit.ly/3X1yPW0

"Fear of recurrence can be persistent for survivors of early-stage breast cancer, but tools are available to help oncologists and patients understand and manage their risk of recurrence." Tune in to Susan G. Komen's Breast Cancer Breakthroughs Episode 8: Navigating Breast Cancer Recurrence to learn how the Breast Cancer Index test can help healthcare providers work with their patients to make important decisions regarding extended endocrine therapy. https://bit.ly/3J8ZzPY

About 154,000 women in the U.S. are living with metastatic breast cancer. Metastatic breast cancer is considered stage IV breast cancer and their is no cure. When breast cancer moves from the breast to other parts of the body, most commonly the brain, bone, liver or lungs, it is staged as metastatic disease. Twisted Pink is funding research to provide hope to those living with stage IV breast cancer. You can help with your support today! #stageIVneedsmore, #researchnotribbons, #twistedpink, #breastcanceraction, #breastcancerawareness, #curebreastcancer

Ever considered participating in a breast cancer clinical trial? LBCA’s latest 5-minute PSA addresses why they are so crucial for finding treatments for all breast cancer types. In “Why Clinical Trial Participation is Important to Advance Breast Cancer Treatment,” Breast cancer patients and oncologists discuss their experience with clinical trials and explain why participating in them is important to ensure diversity and to ensure that research finds new treatments for breast cancers that are effective for all. Watch the video and share it with other patients you know: https://lnkd.in/eBRMyXcp #breastcancerresearch #breastcancerclinicaltrials #breastcancertreatments #breastcancerpsa

Happening now! The standard of care hormone therapy has remained the same for early ER-positive breast cancer for 20 years because it is so effective – but can it be better? In this episode of Breast Cancer Breakthroughs, we’ll hear from experts Dr. Sean Fanning and Dr. Priya Rastogi about how researchers are changing the game with new hormone therapies for early ER-positive breast cancer to further improve outcomes for patients. Watch here: https://bit.ly/3X1yPW0

Findings from our Global Advanced/Metastatic Breast Cancer Patient Biomarker Survey emphasise a need for enhanced information and support for individuals to understand what type of breast cancer they have and take part in decisions about their care. As #ASCO2024 draws to a close, it is critical that the oncology community considers how scientific developments and treatments are communicated to patients. To learn more about our call-to-action for the metastatic breast cancer community visit: https://bit.ly/4bCRpvH, or visit booth # 11014 at #ASC02024 to learn more about our initiatives. #Biomarkers #SharedDecisionMaking #PrecisionMedicine #LivingwithMetastaticBreastCancer

October is Breast Cancer Awareness Month. In honor of this year’s theme, “No one should face breast cancer alone,” GMR affirms our dedication to spreading awareness and promoting early detection screening. We stand with those affected by this disease to provide support, strength and hope. You are not alone. Learn more about how to be proactive in the fight against breast cancer. #breastcancerawareness https://ow.ly/GN4X50Twytu

Clinical trials aren’t discussed frequently enough with patients. Our latest State of Patient Empowerment survey found that only 28% of breast cancer patients are presented with a clinical trial. But, there are exciting new trials underway in early breast cancer. ⏩to the 5-min mark of our latest Ask the Expert webinar series to learn more about some of the trials discussed at the San Antonio Breast Cancer Symposium. https://lnkd.in/eueTJ_ud #SABCS #breastcancer #breastcancertrials #earlystagebreastcancer

On this #NationalClinicalTrialsDay, we are highlighting a troubling finding published by the Lancet Breast Cancer Commission which shows that participation in breast cancer clinical trials is low and does not reflect the diversity of the breast cancer community. To find the cures for breast cancer, all communities must be represented in breast cancer research. This is why Komen launched ShareForCures, a revolutionary breast cancer research registry that connects scientists with information from people who have or have had breast cancer. To join this inclusive registry, or learn more https://bit.ly/3MMwqwd

October is Breast Cancer Awareness Month. In honor of this year’s theme, “No one should face breast cancer alone,” GMR affirms our dedication to spreading awareness and promoting early detection screening. We stand with those affected by this disease to provide support, strength and hope. You are not alone. Learn more about how to be proactive in the fight against breast cancer. #breastcancerawareness https://ow.ly/QMrS50Twytt